"It's been a tremendous year and we're not even finished with first quarter. In addition to the recent coup secured with our exclusive retail partner, we've been underway on innovative solutions for medical and industrial sectors in addition to the successes we've had with Pit Solution and GC 2000 technologies," states Jared Hochstedler, CEO and President of the progressive green biotech company. "We have reviewed existing licensing agreements and product orders and have been conservative with received Letters of Intent and projected manufacturing orders and biotech licensing requests from several commercial vendors in sectors anywhere among the steel industry, medical fields and water treatment, among others and have estimated, moderately, projected gross sales are in excess of $136,000,000.00 ($136M) by end of 4th quarter, 2009. This does not include pending prospective contracts with Southeast Asia and the multitude of formula applications therein."
News 
Market Data 
Discover 
AI
